Azelis Group NV (AZLGF)
OTC PINK OTC PINK Primary 
Azelis: Persistent Margin Pressure Creates Initial Buying Opportunity
Azelis remains a robust free cash flow generator despite sector-wide margin pressure and modest revenue declines. AZE trades at a double-digit free cash flow yield, with non-cash amortization weighing on reported earnings but not on cash generation. Management prioritizes M&A over dividends, leveraging sector weakness to pursue bolt-on acquisitions and enhance long-term value.
IMCD And Azelis: Two Specialty Chemical Distributors With Massive Return Potential
IMCD (IMCDY) and Azelis (AZLGF) are leading, capital-light specialty chemical distributors poised for 20%+ annual returns over 5-10 years. Both benefit from industry consolidation, growing scale, exclusive supplier relationships, and strong integration of acquisitions, supporting steady organic and inorganic growth. IMCD stands out with a cleaner balance sheet, longer public track record, and greater APAC exposure, offering a superior risk-adjusted return profile.
Azelis: Correction Puts The Stock In The 'Buy' Zone
Azelis, listed on Euronext Brussels, has a market cap of approximately 3.7B EUR and generates strong cash flow, making it an attractive investment. Despite stable net income, Azelis' underlying free cash flow of 277M EUR and a proposed dividend increase highlight its financial strength. The company's exposure to US tariffs should be limited, with a positive outlook for revenue growth, especially in the Americas.
